Open access
Sep 2026
A retrospective, observational cohort study of treatment patterns and outcomes among patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer in the United States following endocrine therapy
The findings reinforce the high unmet need in patients with HR+/HER2’s metastatic breast cancer whose disease has become resistant to ET, highlighting the need for effective treatments in this setting.
J. O'Shaughnessy, M. Rehnquist, N. Sadetsky et al.
· Breast Cancer Research and T... · 0 citations